<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="mja252622" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med J Aust</journal-id><journal-id journal-id-type="iso-abbrev">Med J Aust</journal-id><journal-id journal-id-type="doi">10.5694/(ISSN)1326-5377</journal-id><journal-id journal-id-type="publisher-id">MJA2</journal-id><journal-title-group><journal-title>The Medical Journal of Australia</journal-title></journal-title-group><issn pub-type="ppub">0025-729X</issn><issn pub-type="epub">1326-5377</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40058771</article-id><article-id pub-id-type="pmc">PMC11972595</article-id>
<article-id pub-id-type="doi">10.5694/mja2.52622</article-id><article-id pub-id-type="publisher-id">MJA252622</article-id><article-id pub-id-type="other">mja23.00781.R4</article-id><article-categories><subj-group subj-group-type="JEL-classification"><subject>Poisoning</subject></subj-group><subj-group subj-group-type="JEL-classification"><subject>Cardiovascular Diseases</subject></subj-group><subj-group subj-group-type="JEL-classification"><subject>Hematologic Diseases</subject></subj-group><subj-group subj-group-type="overline"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Research and Reviews</subject><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Early cardiovascular collapse after envenoming by snakes in Australia, 2005&#x02013;2020: an observational study (<styled-content style="fixed-case" toggle="no">ASP</styled-content>&#x02010;31)</article-title><alt-title alt-title-type="right-running-head">Early cardiovascular collapse after envenoming by snakes in Australia, 2005&#x02013;2020: an observational study (<styled-content style="fixed-case" toggle="no">ASP</styled-content>&#x02010;31)</alt-title></title-group><contrib-group><contrib id="mja252622-cr-0001" contrib-type="author" corresp="yes"><name><surname>Isbister</surname><given-names>Geoffrey K</given-names></name><xref rid="mja252622-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mja252622-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="mja252622-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>geoff.isbister@newcastle.edu.au</email></address></contrib><contrib id="mja252622-cr-0002" contrib-type="author"><name><surname>Isoardi</surname><given-names>Katherine Z</given-names></name><xref rid="mja252622-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="mja252622-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="mja252622-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="mja252622-cr-0003" contrib-type="author"><name><surname>Chiew</surname><given-names>Angela L</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0079-5056</contrib-id><xref rid="mja252622-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="mja252622-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="mja252622-cr-0004" contrib-type="author"><name><surname>Jenkins</surname><given-names>Shane</given-names></name><xref rid="mja252622-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mja252622-cr-0005" contrib-type="author"><name><surname>Buckley</surname><given-names>Nicholas A</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6326-4711</contrib-id><xref rid="mja252622-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mja252622-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="mja252622-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>The University of Sydney</institution>
<city>Sydney</city>
<named-content content-type="country-part">NSW</named-content>
</aff><aff id="mja252622-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>The University of Newcastle</institution>
<city>Newcastle</city>
<named-content content-type="country-part">NSW</named-content>
</aff><aff id="mja252622-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">NSW Poisons Information Centre</named-content>
<institution>Children's Hospital at Westmead</institution>
<city>Sydney</city>
<named-content content-type="country-part">NSW</named-content>
</aff><aff id="mja252622-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Princess Alexandra Hospital</institution>
<city>Brisbane</city>
<named-content content-type="country-part">QLD</named-content>
</aff><aff id="mja252622-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>The University of Queensland</institution>
<city>Brisbane</city>
<named-content content-type="country-part">QLD</named-content>
</aff><aff id="mja252622-aff-0006">
<label>
<sup>6</sup>
</label>
<institution>Prince of Wales Hospital and Community Health Services</institution>
<city>Sydney</city>
<named-content content-type="country-part">NSW</named-content>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<email>geoff.isbister@newcastle.edu.au</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2025</year></pub-date><volume>222</volume><issue seq="80">6</issue><issue-id pub-id-type="doi">10.5694/mja2.v222.6</issue-id><fpage>313</fpage><lpage>317</lpage><history>
<date date-type="received"><day>02</day><month>8</month><year>2023</year></date>
<date date-type="accepted"><day>06</day><month>9</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 AMPCo Pty Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Medical Journal of Australia</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of AMPCo Pty Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MJA2-222-313.pdf"/><abstract><title>Abstract</title><sec id="mja252622-sec-0001"><title>Objectives</title><p>To investigate the frequency, timing, and characteristics of cardiovascular collapse after snakebite in Australia, and the complications of collapse following envenoming.</p></sec><sec id="mja252622-sec-0002"><title>Study design</title><p>Observational study; analysis of prospectively collected demographic and clinical data.</p></sec><sec id="mja252622-sec-0003"><title>Setting, participants</title><p>People with confirmed snake envenoming recruited to the Australian Snakebite Project at one of 200 participating Australian hospitals, 1 July 2005 &#x02013; 30 June 2020.</p></sec><sec id="mja252622-sec-0004"><title>Main outcome measures</title><p>Time from snakebite to collapse; post&#x02010;collapse complications (cardiac arrest, seizures, death).</p></sec><sec id="mja252622-sec-0005"><title>Results</title><p>Of 1259 envenomed people, 157 (12%) collapsed within 24 hours of the snakebite; venom&#x02010;induced consumption coagulopathy (VICC) was determined in all 156 people for whom coagulation testing could be performed. The exact time between bite and collapse was known for 149 people (median, 20&#x02009;min; interquartile range, 15&#x02013;30&#x02009;min; range, 5&#x02013;115&#x02009;min); the time exceeded 60 minutes for only two people, each after releasing tight bandages 60 minutes after the bite. The collapse preceded hospital arrival in 132 cases (84%). Brown snake (<italic toggle="no">Pseudonaja</italic> spp.) envenoming was the leading cause of collapse (103 cases, 66%). Forty&#x02010;two collapses (27%) were followed by cardiac arrest, 49 (31%) by seizures (33 without cardiac arrest), and five by apnoea; collapse was associated with hypotension in all 24 people whose blood pressure could be measured at or close to the time of collapse. Twenty&#x02010;five people who collapsed died (16%), and seven of the envenomed people who did not collapse (0.6%; difference: 15 percentage points; 95% confidence interval, 8&#x02013;21 percentage points). The deaths of 21 of the 25 people who collapsed were immediately associated with the cardiac arrest that followed the collapse; three people who did not have cardiac arrests died later of intracranial haemorrhage, and one of hyperthermia. The proportion of people who had collapsed before reaching hospital was larger for people who died of post&#x02010;collapse cardiac arrest (13 of 21, 62%) than for those who survived (6 of 21, 28%).</p></sec><sec id="mja252622-sec-0006"><title>Conclusion</title><p>Collapse after Australian snake envenoming almost always occurred within 60 minutes of the bite, was always accompanied by VICC, and most frequently followed brown snake bites. Poorer outcomes, including cardiac arrest, seizures, and death, were more frequent for people who collapsed than for those who did not. Outcomes for people who collapsed before medical care arrived were poorer than for those who collapsed in hospital or in an ambulance.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mja252622-kwd-0001">Snake bites</kwd><kwd id="mja252622-kwd-0002">Hypotension</kwd><kwd id="mja252622-kwd-0003">Coagulation disorders</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Health and Medical Research Council
</institution><institution-id institution-id-type="doi">10.13039/501100000925</institution-id></institution-wrap></funding-source><award-id>1061041</award-id><award-id>1110343</award-id><award-id>2007726</award-id><award-id>2016380</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="5"/><word-count count="3700"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:06.04.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="mja252622-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="mja252622-blkfxd-0001"><p>
<bold>The known</bold>: Collapse is an infrequent but important manifestation of snake envenoming in Australia.</p><p>
<bold>The new</bold>: People who collapse after snake envenoming in Australia do so within an hour of the bite and usually before they reach hospital. It is associated with venom&#x02010;induced consumption coagulopathy, and is most frequent after brown snake bites. Rates of cardiac arrest and death are higher for people who collapse than for those who do not.</p><p>
<bold>The implications</bold>: Early collapse is a high risk feature of Australian snake envenoming. It requires prompt identification and cardiopulmonary resuscitation.</p></boxed-text>
</p><sec sec-type="opening-section" id="mja252622-sec-0010"><p>Snakebite causes substantial numbers of injuries and deaths around the world,<xref rid="mja252622-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="mja252622-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> including in Australia.<xref rid="mja252622-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Australian snake envenoming causes a constellation of clinical effects that depend on the snake type and the venom injected. Venom&#x02010;induced consumption coagulopathy (VICC) is the most frequent effect, followed by thrombotic microangiopathy, myotoxicity, and neurotoxicity.<xref rid="mja252622-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="mja252622-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> An unusual effect of envenoming by Australian elapids is collapse within an hour of the bite or loss of consciousness;<xref rid="mja252622-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> this is the most frequent mechanism of death following snakebite in Australia.<xref rid="mja252622-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>Early collapse, cardiovascular collapse, or hypotensive collapse have been reported following bites by brown snakes,<xref rid="mja252622-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> tiger snakes (<italic toggle="yes">Notechis scutatus</italic>),<xref rid="mja252622-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> rough&#x02010;scale snakes (<italic toggle="yes">Tropidechis carinatus</italic>),<xref rid="mja252622-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> and taipans (<italic toggle="yes">Oxyuranus scutellatus</italic>).<xref rid="mja252622-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Collapse or, more frequently, hypotension have been reported following snakebite in other parts of the world, mainly after viper envenoming,<xref rid="mja252622-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="mja252622-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> but from a variety of different mechanisms.<xref rid="mja252622-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="mja252622-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>
</p><p>The cause of collapse following bites by Australian elapids has been debated. It has been attributed to a myocardial depressant in the venom or intracardiac clot formation,<xref rid="mja252622-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="mja252622-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> but more recent studies in rodents suggest that the mechanism involves the secondary release of vasodilatory substances.<xref rid="mja252622-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="mja252622-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Whatever the mechanism, hypotensive collapse occurs within minutes in experimental animals, and within one hour of envenoming in humans.<xref rid="mja252622-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>A recent New South Wales coronial report focused attention on early collapse and death following brown snake envenoming.<xref rid="mja252622-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> The coroner recommended several changes to the observation of patients, as well as considering administering antivenom to people not exhibiting signs of envenoming. However, the published information about the timing of the collapse, the risk of cardiac arrest, seizure, and death in this case was limited. These factors are critical for the probable effectiveness of antivenom in this situation.</p><p>We therefore investigated the frequency, timing, and characteristics of cardiovascular collapse after snakebite in Australia, and the complications of collapse following envenoming.</p></sec><sec sec-type="methods" id="mja252622-sec-0011"><title>Methods</title><p>To assess the characteristics of and complications in people who experienced cardiovascular collapse following snakebite and to compare them with those for other people who had been envenomed, we reviewed cases in the Australian Snakebite Project (ASP) cohort. The Australian Snakebite Project (ASP) is a prospective, multicentre observational study that recruits people with suspected snakebite.</p><p>All people who presented to any of more than 200 participating Australian hospitals with suspected or confirmed snakebite during 1 July 2005 &#x02013; 30 June 2020 were eligible for recruitment by ASP investigators. People with suspected or confirmed snakebite are identified by calls to a national free call number, calls to the National Poison Centre Network, by clinical toxicologists, or hospital investigators. When a case is identified, consent, patient information, and datasheet forms are faxed or emailed to the treating doctor. Demographic data and information about the circumstances of the bite, clinical effects, laboratory investigations, complications, and treatment are collected.<xref rid="mja252622-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The information is entered into Microsoft Access, and any missing information is obtained from the patient's medical record. All cases are reviewed by the chief investigator (author GKI). An additional blood sample is collected, and the serum frozen and transported for venom assays when available. The snake type is determined by expert identification (professional working with snakes at a museum or zoo) when the snake is available, or by venom&#x02010;specific enzyme immunoassay when blood is available.<xref rid="mja252622-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p><p>For each case, we extracted patient demographic data and information on bite circumstances, the timing of collapse (if applicable), time to hospital arrival, clinical syndromes of Australian snake envenoming (VICC, myotoxicity, neurotoxicity),<xref rid="mja252622-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> complications (cardiac arrest, seizure, death, thrombotic microangiopathy), length of stay, and antivenom treatment. Collapse was defined as any physical collapse in an upright person associated with loss of consciousness (ie, not simply a fall) or any loss of consciousness in a recumbent patient (eg, on an ambulance stretcher or hospital bed) within 24 hours of snakebite. We excluded people for whom there was clear evidence of collapse associated with venom hypersensitivity or anaphylaxis, a rare event confined to snake handlers.<xref rid="mja252622-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p><p>We summarise continuous variables as medians with interquartile ranges (IQRs) and ranges. The statistical significance of differences in dichotomous outcomes was assessed in Fisher exact tests, that of differences in continuous variables with Mann&#x02013;Whitney tests. All analyses were performed in GraphPad Prism 9.5 for Windows.</p><sec id="mja252622-sec-0012"><title>Ethics approval</title><p>The study was approved by human research ethics committees of the Northern Territory Department of Health and Menzies School of Health Research (04/08), the Hunter New England Local Health District (HREC/15/HNE/29), the Royal Perth Hospital and South Metro Area Health Service (RA&#x02010;08/003), the Western Australian Country Health Service (2008: 03, REC200835), Tasmania Network (H00109965), and the Gold Coast Health Service District. (200835).</p></sec></sec><sec sec-type="results" id="mja252622-sec-0013"><title>Results</title><p>A total of 2180 people with snakebite were recruited to ASP during 2005&#x02013;20; 1259 had been envenomed, of whom 157 (12%) subsequently collapsed (Box&#x000a0;<xref rid="mja252622-fea-0001" ref-type="boxed-text">1</xref>). Of the 157 people who experienced collapse, 125 (80%) were male, their median age was 43 years (IQR, 26&#x02013;56 years), and 20 (13%) were snake handlers; the characteristics of envenomed people who did not collapse were similar (Box&#x000a0;<xref rid="mja252622-fea-0002" ref-type="boxed-text">2</xref>). The proportions of envenoming cases followed by collapse were similar by state and territory, remoteness category of hospital (Box&#x000a0;<xref rid="mja252622-fea-0002" ref-type="boxed-text">2</xref>) and by year (<xref rid="mja252622-supitem-0001" ref-type="supplementary-material">Supporting Information</xref>, figure&#x000a0;1).</p><boxed-text position="float" content-type="Box" id="mja252622-fea-0001"><label>Box 1</label><caption><title>Flow chart of people recruited for the Australian Snakebite Project, 1 July 2005 &#x02013; 30 June 2020, by envenoming, post&#x02010;envenoming collapse, and post&#x02010;collapse cardiac arrest status</title></caption><p>
<boxed-text position="anchor" content-type="graphic" id="mja252622-blkfxd-0002"><graphic xlink:href="MJA2-222-313-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></boxed-text><boxed-text position="float" content-type="Box" id="mja252622-fea-0002"><label>Box 2</label><caption><title>Characteristics of the 1259 envenomed people recruited for the Australian Snakebite Project, 1 July 2005 &#x02013; 30 June 2020, and their snakebites, by whether they collapsed within 24 hours of the snakebite</title></caption><p>
<table-wrap position="anchor" id="jats-table-wrap-1"><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="bottom" rowspan="1" colspan="1">Collapse</th><th align="left" valign="bottom" rowspan="1" colspan="1">No collapse</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of people</td><td align="center" valign="top" rowspan="1" colspan="1">157</td><td align="center" valign="top" rowspan="1" colspan="1">1102</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years), median (IQR)</td><td align="center" valign="top" rowspan="1" colspan="1">43 (26&#x02013;56)</td><td align="center" valign="top" rowspan="1" colspan="1">41 (24&#x02013;57)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">125 (80%)</td><td align="center" valign="top" rowspan="1" colspan="1">793 (72%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="top" rowspan="1" colspan="1">32 (20%)</td><td align="center" valign="top" rowspan="1" colspan="1">308 (28%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Snake handler</td><td align="center" valign="top" rowspan="1" colspan="1">20 (13%)</td><td align="center" valign="top" rowspan="1" colspan="1">182 (17%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">State/territory</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Australian Capital Territory</td><td align="left" valign="top" rowspan="1" colspan="1">1 (1%)</td><td align="left" valign="top" rowspan="1" colspan="1">10 (1%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">New South Wales</td><td align="center" valign="top" rowspan="1" colspan="1">47 (30%)</td><td align="center" valign="top" rowspan="1" colspan="1">393 (36%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Northern Territory</td><td align="center" valign="top" rowspan="1" colspan="1">9 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">34 (3%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Queensland</td><td align="center" valign="top" rowspan="1" colspan="1">60 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">317 (29%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">South Australia</td><td align="center" valign="top" rowspan="1" colspan="1">3 (2%)</td><td align="center" valign="top" rowspan="1" colspan="1">18 (2%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tasmania</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (2%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Victoria</td><td align="center" valign="top" rowspan="1" colspan="1">13 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">141 (13%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Western Australia</td><td align="center" valign="top" rowspan="1" colspan="1">20 (13%)</td><td align="center" valign="top" rowspan="1" colspan="1">162 (15%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Geographic remoteness (hospital)<xref rid="mja252622-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Major city</td><td align="center" valign="top" rowspan="1" colspan="1">43 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">409 (37%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Inner regional</td><td align="center" valign="top" rowspan="1" colspan="1">63 (40%)</td><td align="center" valign="top" rowspan="1" colspan="1">447 (41%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Outer regional</td><td align="center" valign="top" rowspan="1" colspan="1">24 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">152 (13%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Remote</td><td align="center" valign="top" rowspan="1" colspan="1">21 (13%)</td><td align="center" valign="top" rowspan="1" colspan="1">59 (5%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Very remote</td><td align="center" valign="top" rowspan="1" colspan="1">5 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">35 (3%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Snake type</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Brown snake (<italic toggle="yes">Pseudonaja</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">103 (66%)</td><td align="center" valign="top" rowspan="1" colspan="1">280 (25%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tiger snake (<italic toggle="yes">Notechis</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">179 (16%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Rough&#x02010;scale snake (<italic toggle="yes">Tropidechis carinatus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">78 (7%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tiger snake group*</td><td align="center" valign="top" rowspan="1" colspan="1">5 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">44 (4%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Taipan (<italic toggle="yes">Oxyuranus scutellatus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">51 (5%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Broad&#x02010;headed snake (<italic toggle="yes">Hoplocephalus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1%)</td><td align="center" valign="top" rowspan="1" colspan="1">34 (3%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Black snake (<italic toggle="yes">Pseudechis</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">240 (22%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Death adder (<italic toggle="yes">Acanthophis</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">37 (3%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">20 (2%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">19 (12%)</td><td align="center" valign="top" rowspan="1" colspan="1">139 (13%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Clinical syndromes</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Venom&#x02010;induced consumption coagulopathy</td><td align="center" valign="top" rowspan="1" colspan="1">156 (99%)</td><td align="center" valign="top" rowspan="1" colspan="1">757 (69%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Thrombotic microangiopathy</td><td align="center" valign="top" rowspan="1" colspan="1">8 (5%)</td><td align="center" valign="top" rowspan="1" colspan="1">106 (10%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Neurotoxicity</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">119 (11%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Myotoxicity</td><td align="center" valign="top" rowspan="1" colspan="1">7 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">190 (17%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hospital length of stay (hours), median (IQR)</td><td align="center" valign="top" rowspan="1" colspan="1">43 (26&#x02013;75)</td><td align="center" valign="top" rowspan="1" colspan="1">38 (22&#x02013;65)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antivenom administered</td><td align="center" valign="top" rowspan="1" colspan="1">150 (96%)</td><td align="center" valign="top" rowspan="1" colspan="1">903 (82%)</td></tr></tbody></table><table-wrap-foot id="mja252622-ntgp-0001"><fn id="mja252622-note-0001"><p>IQR = interquartile range. *Tiger snake or rough&#x02010;scaled snake (unable to distinguish with venom&#x02010;specific enzyme immunoassay).</p></fn></table-wrap-foot></table-wrap>
</p></boxed-text><sec id="mja252622-sec-0016"><title>Characteristics of cases of envenoming followed by collapse</title><p>One hundred and three of the 157 people who collapsed (66%) were envenomed by brown snakes, 29 (19%) by tiger snakes (<italic toggle="yes">Notechis</italic> spp.) or rough&#x02010;scaled snakes (<italic toggle="yes">T. carinatus</italic>), four (5%) by taipans (<italic toggle="yes">Oxyuranus</italic> spp.), and none by death adders (<italic toggle="yes">Acanthophis</italic> spp.) or black snakes (<italic toggle="yes">Pseudechis</italic> spp.); the snake was not identified in nineteen cases (12%). In cases not followed by collapse, the proportion of envenomings by brown snakes was smaller (280 cases, 25%), and 240 cases involved black snakes (22%) (Box&#x000a0;<xref rid="mja252622-fea-0002" ref-type="boxed-text">2</xref>). Collapse was more frequent following brown snake envenoming (103 of 383 cases, 27%) than envenoming by tiger or rough&#x02010;scale snakes (29 of 330, 9%) or taipans (4 of 55, 7%). VICC was determined in all 156 patients for whom coagulation tests were performed (one person who collapsed died before reaching a hospital). Four people experienced neurotoxicity, and seven myotoxicity. There was evidence of venom hypersensitivity in one patient who collapsed, and they were excluded from further analyses.</p><p>The median time from snakebite to collapse in the 149 cases for which time of collapse was known was 20 minutes (IQR, 15&#x02013;30&#x02009;min; range, 5&#x02013;115&#x02009;min) (Box&#x000a0;<xref rid="mja252622-fea-0003" ref-type="boxed-text">3</xref>). The two people who collapsed more than 60 minutes after the bite (90 or 115 minutes) did not have any suggestive symptoms, and coagulation study findings were normal on arrival at hospital (respectively 70 and 30 minutes after the bite), but they collapsed after their bandage was removed; one was a snake&#x02010;handler who had applied a double pressure bandage immediately after the bite. Collapse preceded arrival at the hospital in 132 cases (84%). A pressure bandage with immobilisation had been applied to 130 of 157 people (83%) who collapsed; it had been applied before the collapse in 50 cases (32%) at a median of ten minutes (IQR, 5&#x02013;15&#x02009;min) after the bite. No patient who collapsed had received antivenom prior to collapse.</p><boxed-text position="float" content-type="Box" id="mja252622-fea-0003"><label>Box 3</label><caption><title>Distribution of time to hospital and to collapse, by site of collapse*</title></caption><p>
<boxed-text position="anchor" content-type="graphic" id="mja252622-blkfxd-0003"><graphic xlink:href="MJA2-222-313-g002.jpg" position="anchor" id="jats-graphic-3"/></boxed-text>
</p><p>* Purple bars mark the median values for 25 people who collapsed in hospital, grey bars for the 132 people who collapsed before reaching hospital.</p></boxed-text></sec><sec id="mja252622-sec-0018"><title>Complications of collapse</title><p>Forty&#x02010;two collapses (27%) were followed by cardiac arrests, 49 (31%) by seizures (33 without cardiac arrest), and five by apnoea (Box&#x000a0;<xref rid="mja252622-fea-0004" ref-type="boxed-text">4</xref>). Two patients were intubated following collapse because of agitation, one because of hypotension. Collapse was associated with hypotension in all 24 people whose blood pressure could be measured at or close to the time of collapse. All people who collapsed without complications before arriving at hospital arrived with recovered or recovering level of consciousness. Twenty&#x02010;one children (under 18 years) collapsed; eleven (52%) had seizures, eight had cardiac arrests (38%) (Box&#x000a0;<xref rid="mja252622-fea-0004" ref-type="boxed-text">4</xref>).</p><boxed-text position="float" content-type="Box" id="mja252622-fea-0004"><label>Box 4</label><caption><title>Complications, deaths, and intubation for 157 people who collapsed after snakebite envenoming, by age group</title></caption><p>
<table-wrap position="anchor" id="jats-table-wrap-2"><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Outcome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Collapse</th><th align="left" valign="bottom" rowspan="1" colspan="1">Adults</th><th align="left" valign="bottom" rowspan="1" colspan="1">Children</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of patients</td><td align="center" valign="top" rowspan="1" colspan="1">157</td><td align="center" valign="top" rowspan="1" colspan="1">136</td><td align="center" valign="top" rowspan="1" colspan="1">21</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Seizure</td><td align="center" valign="top" rowspan="1" colspan="1">49 (31%)</td><td align="center" valign="top" rowspan="1" colspan="1">38 (28%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (52%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardiac arrest</td><td align="center" valign="top" rowspan="1" colspan="1">42 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">34 (25%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (38%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Respiratory arrest (apnoea)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Died</td><td align="center" valign="top" rowspan="1" colspan="1">25 (16%)</td><td align="center" valign="top" rowspan="1" colspan="1">22 (16%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (14%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intubated (immediately after collapse)</td><td align="center" valign="top" rowspan="1" colspan="1">37 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">32 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (24%)</td></tr></tbody></table></table-wrap>
</p></boxed-text><p>Twenty&#x02010;five people who collapsed (16%) died, as did seven (0.6%) who did not collapse (difference: 15 percentage points; 95% confidence interval, 8&#x02013;21 percentage points). The deaths of 21 of the 25 people who collapsed were immediately associated with the cardiac arrest that followed the collapse; four people who did not have cardiac arrests died later from intracranial haemorrhage (three people) or hyperthermia (one person). Among the 42 people who collapsed and had cardiac arrests, return of spontaneous circulation was reported in thirty; median time to return of spontaneous circulation was shorter for the eighteen who survived (5&#x02009;min; IQR, 2&#x02013;6&#x02009;min; range, 1&#x02013;40&#x02009;min) than for the twelve who died (45&#x02009;min; IQR, 32&#x02013;60&#x02009;min; range, 15&#x02013;120&#x02009;min; <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.001). Thirteen of the 21 people who died following cardiac arrests had collapsed before reaching hospital, six in the ambulance or in hospital; twelve of the 21 who survived had collapsed in the ambulance or in hospital (<xref rid="mja252622-supitem-0001" ref-type="supplementary-material">Supporting Information</xref>, table&#x000a0;1).</p></sec></sec><sec sec-type="discussion" id="mja252622-sec-0020"><title>Discussion</title><p>We found that collapse following snakebite usually occurs soon after the bite and is associated with more severe outcomes, including cardiac arrest and death, than envenoming not followed by collapse. Collapse was most frequent after brown snake envenoming, and was always accompanied by VICC. As the median time to collapse was 20 minutes, and it was within 60 minutes of the bite in 99% of cases, 84% of collapses took place before the person arrived at hospital. Antivenom had never been administered before the collapse, indicating the importance of immediate resuscitation after severe snake envenoming. This finding was reinforced by the fact that 19 of the 21 people who collapsed and survived cardiac arrests had received immediate resuscitation because they were in hospital or with ambulance officers, or had received immediate bystander resuscitation (<xref rid="mja252622-supitem-0001" ref-type="supplementary-material">Supporting Information</xref>, table&#x000a0;1).</p><p>The recent coronial report on a death following collapse in hospital after brown snake envenoming recommended that antivenom be administered as soon as evidence of envenoming is noted, based on medical assessment, even if laboratory results are not yet available.<xref rid="mja252622-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> However, we found that 84% of collapses preceded arrival at hospital, and in no case could antivenom be administered before a collapse. As collapse typically occurs early, and is often the first indication of envenoming, administering antivenom to prevent collapse is practically very difficult. More importantly, we found that recognising collapse and immediate resuscitation are crucial, and poor outcomes were more frequent when resuscitation, and consequently return of spontaneous circulation, were delayed.</p><p>More than one&#x02010;quarter of brown snake envenomings were followed by collapse, a larger proportion than for tiger snake or taipan envenomings. Envenoming by snakes that do not cause VICC (death adders and black snakes) was not followed by collapse. That is, collapse is associated with more severe envenoming, but it also suggests brown snake envenoming, particularly in the absence of neurotoxicity or myotoxicity.</p><sec id="mja252622-sec-0021"><title>Limitations</title><p>Limitations of the study included uncertainty about the time of collapse, difficulties in measuring blood pressure or other vital characteristics at the time of the collapse, and some collapses not being witnessed. Time of collapse was based on the report to the admitting doctor, ambulance or other health care workers. Further, people who presented to hospital after a delay might not have recalled a collapse, particularly if it was not witnessed. However, the fact that collapse occurred early meant that most people who collapsed were transported to hospital immediately. As no&#x02010;one received it early enough, the effectiveness of antivenom for preventing collapse is unknown; its administration prior to reaching hospital seems, in any case, to be impractical. We could not assess the effect of other medical conditions on collapse because this information is not routinely collected in ASP. Finally, people who collapsed may have been more likely to enrol in ASP than people who did not.</p></sec><sec sec-type="conclusions" id="mja252622-sec-0022"><title>Conclusion</title><p>Collapse after Australian snake envenoming almost always occurred within 60 minutes of the bite, and was always accompanied by VICC; it most frequently followed brown snake bites. Collapse is associated with poorer outcomes than for people who do not collapse after snakebite, including higher rates of cardiac arrest and death, particularly if resuscitation is delayed. A larger proportion of people who survived subsequent cardiac arrests than of those who did not had collapsed in the ambulance on the way to hospital or in hospital, and their median time to return of spontaneous circulation was shorter. We propose that &#x0201c;early collapse&#x0201d; be used to describe this common and potentially lethal phenomenon: collapse within one hour of envenoming, or within two hours if a pressure bandage has been applied. This definition could be useful for assessing its frequency after snakebite elsewhere in the world.</p></sec><sec id="mja252622-sec-0065a"><title>Open access</title><p>Open access publishing facilitated by The University of Newcastle, as part of the Wiley &#x02013; the University of Newcastle agreement via the Council of Australian University Librarians.</p></sec><sec sec-type="COI-statement" id="mja252622-sec-4001"><title>Competing interests</title><p>No relevant disclosures.</p></sec></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="mja252622-supitem-0001" position="float" content-type="local-data"><caption><p>
Supplementary results
</p></caption><media xlink:href="MJA2-222-313-s001.pdf"/></supplementary-material></sec></body><back><ack id="mja252622-sec-4000"><title>Acknowledgements</title><p>We acknowledge Kylie Tape (University of Newcastle) for data collection and data entry for the Australian Snakebite Project.</p></ack><ref-list content-type="cited-references" id="mja252622-bibl-0001"><ref id="mja252622-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="mja252622-cit-0001">
<collab collab-type="authors">GBD 2019 Snakebite Envenomation Collaborators</collab>
. <article-title>Global mortality of snakebite envenoming between 1990 and 2019</article-title>. <source>Nat Commun</source>
<year>2022</year>; <volume>13</volume>: <fpage>6160</fpage>.<pub-id pub-id-type="pmid">36284094</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="mja252622-cit-0002">
<string-name>
<surname>Ralph</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Faiz</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>SK</given-names>
</string-name>, et&#x000a0;al. <article-title>Managing snakebite</article-title>. <source>BMJ</source>
<year>2022</year>; <volume>376</volume>: <elocation-id>e057926</elocation-id>.<pub-id pub-id-type="pmid">34996773</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="mja252622-cit-0003">
<string-name>
<surname>Johnston</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Page</surname>
<given-names>CB</given-names>
</string-name>, et&#x000a0;al. <article-title>The Australian Snakebite Project, 2005&#x02013;2015 (ASP&#x02010;20)</article-title>. <source>Med J Aust</source>
<year>2017</year>; <volume>207</volume>: <fpage>119</fpage>&#x02010;<lpage>125</lpage>. <ext-link xlink:href="https://www.mja.com.au/journal/2017/207/3/australian-snakebite-project-2005-2015-asp-20" ext-link-type="uri">https://www.mja.com.au/journal/2017/207/3/australian&#x02010;snakebite&#x02010;project&#x02010;2005&#x02010;2015&#x02010;asp&#x02010;20</ext-link>
<pub-id pub-id-type="pmid">28764620</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="mja252622-cit-0004">
<string-name>
<surname>Isbister</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Page</surname>
<given-names>CB</given-names>
</string-name>, et&#x000a0;al. <article-title>Snakebite in Australia: a practical approach to diagnosis and treatment</article-title>. <source>Med J Aust</source>
<year>2013</year>; <volume>199</volume>: <fpage>763</fpage>&#x02010;<lpage>768</lpage>. <ext-link xlink:href="https://www.mja.com.au/journal/2013/199/11/snakebite-australia-practical-approach-diagnosis-and-treatment" ext-link-type="uri">https://www.mja.com.au/journal/2013/199/11/snakebite&#x02010;australia&#x02010;practical&#x02010;approach&#x02010;diagnosis&#x02010;and&#x02010;treatment</ext-link>
<pub-id pub-id-type="pmid">24329653</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="mja252622-cit-0005">
<string-name>
<surname>Allen</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Buckley</surname>
<given-names>NA</given-names>
</string-name>, et&#x000a0;al; <article-title>ASP Investigators. Clinical effects and antivenom dosing in brown snake (<italic toggle="yes">Pseudonaja</italic> spp.) envenoming: Australian snakebite project (ASP&#x02010;14)</article-title>. <source>PLoS One</source>
<year>2012</year>; <volume>7</volume>: <elocation-id>e53188</elocation-id>.<pub-id pub-id-type="pmid">23300888</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="mja252622-cit-0006">
<string-name>
<surname>Isbister</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>O'Leary</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Elliott</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>SGA</given-names>
</string-name>. <article-title>Tiger snake (<italic toggle="yes">Notechis</italic> spp) envenoming: Australian Snakebite Project (ASP&#x02010;13)</article-title>. <source>Med J Aust</source>
<year>2012</year>; <volume>197</volume>: <fpage>173</fpage>&#x02010;<lpage>177</lpage>. <ext-link xlink:href="https://www.mja.com.au/journal/2012/197/3/tiger-snake-notechis-spp-envenoming-australian-snakebite-project-asp-13" ext-link-type="uri">https://www.mja.com.au/journal/2012/197/3/tiger&#x02010;snake&#x02010;notechis&#x02010;spp&#x02010;envenoming&#x02010;australian&#x02010;snakebite&#x02010;project&#x02010;asp&#x02010;13</ext-link>
<pub-id pub-id-type="pmid">22860796</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="mja252622-cit-0007">
<string-name>
<surname>Gan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>O'Leary</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>SG</given-names>
</string-name>, et&#x000a0;al. <article-title>Envenoming by the rough&#x02010;scaled snake (<italic toggle="yes">Tropidechis carinatus</italic>): a series of confirmed cases</article-title>. <source>Med J Aust</source>
<year>2009</year>; <volume>191</volume>: <fpage>183</fpage>&#x02010;<lpage>186</lpage>. <ext-link xlink:href="https://www.mja.com.au/journal/2009/191/3/envenoming-rough-scaled-snake-tropidechis-carinatus-series-confirmed-cases" ext-link-type="uri">https://www.mja.com.au/journal/2009/191/3/envenoming&#x02010;rough&#x02010;scaled&#x02010;snake&#x02010;tropidechis&#x02010;carinatus&#x02010;series&#x02010;confirmed&#x02010;cases</ext-link>
<pub-id pub-id-type="pmid">19645653</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="mja252622-cit-0008">
<string-name>
<surname>Johnston</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>O'Leary</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>Australian taipan (<italic toggle="yes">Oxyuranus</italic> spp.) envenoming: clinical effects and potential benefits of early antivenom therapy. Australian Snakebite Project (ASP&#x02010;25)</article-title>. <source>Clin Toxicol (Phila)</source>
<year>2017</year>; <volume>55</volume>: <fpage>115</fpage>&#x02010;<lpage>122</lpage>.<pub-id pub-id-type="pmid">27903075</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="mja252622-cit-0009">
<string-name>
<surname>Hermansen</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Krug</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Tj&#x000f8;nnfjord</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Brabrand</surname>
<given-names>M</given-names>
</string-name>. <article-title>Envenomation by the common European adder (<italic toggle="yes">Vipera berus</italic>): a case series of 219 patients</article-title>. <source>Eur J Emerg Med</source>
<year>2019</year>; <volume>26</volume>: <fpage>362</fpage>&#x02010;<lpage>365</lpage>.<pub-id pub-id-type="pmid">30422928</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="mja252622-cit-0010">
<string-name>
<surname>Levine</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ruha</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Wolk</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al; <collab collab-type="authors">ToxIC North American Snakebite Study Group</collab>
. <article-title>When it comes to snakebites, kids are little adults: a comparison of adults and children with rattlesnake bites</article-title>. <source>J Med Toxicol</source>
<year>2020</year>; <volume>16</volume>: <fpage>444</fpage>&#x02010;<lpage>451</lpage>.<pub-id pub-id-type="pmid">32394223</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="mja252622-cit-0011">
<string-name>
<surname>Kakumanu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kemp&#x02010;Harper</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>An <italic toggle="yes">in vivo</italic> examination of the differences between rapid cardiovascular collapse and prolonged hypotension induced by snake venom</article-title>. <source>Sci Rep</source>
<year>2019</year>; <volume>9</volume>: <fpage>20231</fpage>.<pub-id pub-id-type="pmid">31882843</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="mja252622-cit-0012">
<string-name>
<surname>Dias</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Rodrigues</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Renn&#x000f3;</surname>
<given-names>AL</given-names>
</string-name>, et&#x000a0;al. <article-title>Hemodynamic responses to <italic toggle="yes">Lachesis muta</italic> (South American bushmaster) snake venom in anesthetized rats</article-title>. <source>Toxicon</source>
<year>2016</year>; <volume>123</volume>: <fpage>1</fpage>&#x02010;<lpage>14</lpage>.<pub-id pub-id-type="pmid">27720763</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="mja252622-cit-0013">
<string-name>
<surname>Tibballs</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sutherland</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Kerr</surname>
<given-names>S</given-names>
</string-name>. <article-title>Studies on Australian snake venoms, part II: The haematological effects of brown snake (<italic toggle="yes">Pseudonaja</italic>) species in the dog</article-title>. <source>Anaesth Intensive Care</source>
<year>1991</year>; <volume>19</volume>: <fpage>338</fpage>&#x02010;<lpage>442</lpage>.<pub-id pub-id-type="pmid">1767899</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="mja252622-cit-0014">
<string-name>
<surname>Jelinek</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom&#x02010;treated brown snake envenoming</article-title>. <source>Anaesth Intensive Care</source>
<year>2005</year>; <volume>33</volume>: <fpage>36</fpage>&#x02010;<lpage>40</lpage>.<pub-id pub-id-type="pmid">15957689</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="mja252622-cit-0015">
<string-name>
<surname>Chaisakul</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Isbister</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Konstantakopoulos</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>In vivo and in&#x000a0;vitro cardiovascular effects of Papuan taipan (<italic toggle="yes">Oxyuranus scutellatus</italic>) venom: exploring &#x0201c;sudden collapse&#x0201d;</article-title>. <source>Toxicol Lett</source>
<year>2012</year>; <volume>213</volume>: <fpage>243</fpage>&#x02010;<lpage>248</lpage>.<pub-id pub-id-type="pmid">22771951</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="mja252622-cit-0016">
<string-name>
<surname>Chaisakul</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Isbister</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Kuruppu</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>An examination of cardiovascular collapse induced by eastern brown snake (<italic toggle="yes">Pseudonaja textilis</italic>) venom</article-title>. <source>Toxicol Lett</source>
<year>2013</year>; <volume>221</volume>: <fpage>205</fpage>&#x02010;<lpage>211</lpage>.<pub-id pub-id-type="pmid">23830990</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0017"><label>17</label><mixed-citation publication-type="miscellaneous" id="mja252622-cit-0017">
<collab collab-type="authors">Coroners Court of New South Wales</collab>
. <article-title>Inquest into the death of Brent Justin Crough (2018/10493). Date of findings: 7 May</article-title>
<year>2021</year>. <ext-link xlink:href="https://coroners.nsw.gov.au/documents/findings/2021/CROUGH_findings_Tamworth.pdf" ext-link-type="uri">https://coroners.nsw.gov.au/documents/findings/2021/CROUGH_findings_Tamworth.pdf</ext-link> (viewed Feb 2025).</mixed-citation></ref><ref id="mja252622-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="mja252622-cit-0018">
<string-name>
<surname>Kulawickrama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>O'Leary</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Hodgson</surname>
<given-names>WC</given-names>
</string-name>, et&#x000a0;al. <article-title>Development of a sensitive enzyme immunoassay for measuring taipan venom in serum</article-title>. <source>Toxicon</source>
<year>2010</year>; <volume>55</volume>: <fpage>1510</fpage>&#x02010;<lpage>1518</lpage>.<pub-id pub-id-type="pmid">20223258</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="mja252622-cit-0019">
<string-name>
<surname>Isbister</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>SG</given-names>
</string-name>; <string-name>
<given-names>ASP</given-names>
<surname>Investigators</surname>
</string-name>. <article-title>Bites in Australian snake handlers. Australian snakebite project (ASP&#x02010;15)</article-title>. <source>QJM</source>
<year>2012</year>; <volume>105</volume>: <fpage>1089</fpage>&#x02010;<lpage>1095</lpage>.<pub-id pub-id-type="pmid">22875778</pub-id>
</mixed-citation></ref><ref id="mja252622-bib-0020"><label>20</label><mixed-citation publication-type="miscellaneous" id="mja252622-cit-0020">
<collab collab-type="authors">Australian Bureau of Statistics</collab>
. Australian Statistical Geography Standard (ASGS) edition 3, July 2021 &#x02013; June 2026. 27 July 2021. <ext-link xlink:href="https://www.abs.gov.au/statistics/standards/australian-statistical-geography-standard-asgs-edition-3/latest-release" ext-link-type="uri">https://www.abs.gov.au/statistics/standards/australian&#x02010;statistical&#x02010;geography&#x02010;standard&#x02010;asgs&#x02010;edition&#x02010;3/latest&#x02010;release</ext-link> (viewed Feb 2025).</mixed-citation></ref></ref-list></back></article>